Nicola Gökbuget1, Monika Brüggemann2, Michaela Kotrova3, Antonia Volland3, Britta Kehden3, Heiko Trautmann3, Matthias Ritgen3, Ralph Wäsch4, Christoph Faul5, Andreas Viardot6, Stefan Schwartz7, Claudia D Baldus3. 1. Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany. 2. Medical Department II, Hematology/Oncology, University Hospital Schleswig-Holstein, Kiel, Germany. m.brueggemann@med2.uni-kiel.de. 3. Medical Department II, Hematology/Oncology, University Hospital Schleswig-Holstein, Kiel, Germany. 4. Department of Internal Medicine I, University Hospital Freiburg, Freiburg, Germany. 5. Department of Internal Medicine II, University Hospital Tübingen, Hematology, Tübingen, Germany. 6. Department of Internal Medicine III, Hematology and Oncology, University Hospital Ulm, Ulm, Germany. 7. Department of Hematology, Charité Campus Benjamin Franklin, Berlin, Germany.
Authors: Lori Muffly; Vandana Sundaram; Connie Chen; Ilana Yurkiewicz; Eric Kuo; Sarah Burnash; Jay Y Spiegel; Sally Arai; Matthew J Frank; Laura J Johnston; Robert Lowsky; Everett H Meyer; Robert S Negrin; Andrew R Rezvani; Surbhi Sidana; Parveen Shiraz; Judith A Shizuru; Wen-Kai Weng; Michaela Liedtke; Hyma T Vempaty; David B Miklos Journal: Blood Adv Date: 2021-08-24
Authors: Anne Tierens; Tracy L Stockley; Clinton Campbell; Jill Fulcher; Brian Leber; Elizabeth McCready; Peter J B Sabatini; Bekim Sadikovic; Andre C Schuh Journal: Curr Oncol Date: 2021-03-30 Impact factor: 3.677